SITPIN D 10/100
SITPIN D 10/100 is a combination therapy used for effective control of type 2 diabetes mellitus. Each film-coated tablet contains Sitagliptin 100 mg + Dapagliflozin 10 mg. Sitagliptin improves insulin secretion and reduces glucagon levels, while Dapagliflozin helps eliminate excess glucose through urine. This dual mechanism supports better glycemic control, helps reduce HbA1c levels, and contributes to improved overall metabolic health in diabetic patients.
Related products
SITPIN 100
SITPIN 100 contains Sitagliptin 100 mg, a DPP-4 inhibitor used to manage blood sugar levels...
SITAMATA 50-500
SITAMATA 50-500 contains Sitagliptin 50 mg + Metformin Hydrochloride 500 mg, a balanced combination used...
LINANTA M 500
LINANTA M 500 combines Linagliptin 2.5 mg + Metformin Hydrochloride 500 mg, offering dual-action support...
GLIPDIP M
GLIPDIP M is used for effective management of type 2 diabetes mellitus. Each tablet contains...
DUET ACT 4
DUET ACT 4 Tablet is a combination medicine used for effective management of type 2...
DUET ACT 2
DUET ACT 2 combines Glimepiride 2 mg with Metformin 500 mg (SR) for better blood...
DAPAGLIDE 5
COMPOSITION : Dapagliflozin 5 mg
CARBOSTOP 25
CARBOSTOP 25 Tablet is a combination medicine used to manage type 2 diabetes. It contains...
